Results 1 to 10 of about 66,821 (164)
The mechanism of fibronectin 1 promoting papillary thyroid cancer progression by regulating anoikis resistance [PDF]
Scientific ReportsBackground: Papillary thyroid cancer is a common head and neck malignancy with a globally rising incidence. While most patients attain favorable prognosis following standard treatment, a subset develops recurrence and metastasis—two key factors that ...
Shengcan Zhang +5 more
doaj +2 more sources
Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer
Technology in Cancer Research & Treatment, 2022 Objective: This study aimed to evaluate the association between vitamin D receptor (an essential component in the vitamin D signaling pathway) and serum vitamin D as well as its clinical significance in papillary thyroid cancer. Methods: This prospective
Min Jhi Kim MD, PhD +4 more
doaj +1 more source
MicroRNA-96-5p is negatively regulating GPC3 in the metastasis of papillary thyroid cancer
SAGE Open Medicine, 2023 Backgrounds: Papillary thyroid cancer is the most common pathological type of thyroid cancer. miR-96-5p, a member of the miR-183 family, constitute a polycistronic miRNA cluster.
Haibei Hu +6 more
doaj +1 more source
The International Journal of Biological Markers, 2021 Introduction Papillary thyroid cancer corresponds to approximately 1% of all carcinomas; nevertheless, it is the most prevalent endocrine neoplasm in the world.
Ligia C.A. Cardoso-Duarte +10 more
doaj +1 more source
Increased prevalence of chronic lymphocytic thyroiditis in Korean patients with papillary thyroid cancer. [PDF]
PLoS ONE, 2014 BACKGROUND:In recent years, some reports have suggested that papillary thyroid cancers are more frequently associated with lymphocytic thyroiditis or Hashimoto's thyroiditis.
Chang-Mo Oh +9 more
doaj +1 more source
An allelotype of papillary thyroid cancer [PDF]
International Journal of Cancer, 1996 Although papillary carcinoma accounts for approximately 70% of all thyroid cancers, preliminary studies of allelic loss have thus far not identified any areas of chromosomal deletion. We evaluated 30 papillary thyroid carcinomas for chromosomal loss/allelic imbalance by testing at least 2 microsatellite markers from every autosomal arm.
J A, Califano +9 more
openaire +2 more sources
Coexistence of papillary thyroid cancer with Hashimoto thyroiditis [PDF]
Langenbeck's Archives of Surgery, 2012 Conflicting data have been reported with regard to Hashimoto thyroiditis (HT) and risk of malignancy. The aim of this study was to evaluate coexistence of papillary thyroid cancer (PTC) with HT.This is a retrospective cohort study in which HT was diagnosed in 452 (F/M ratio = 405:47, median age 53.5 ± 12.1 years) of 7,545 patients qualified for ...
Konturek, Aleksander +4 more
openaire +4 more sources
The International Journal of Biological Markers, 2021 Background: Long non-coding RNA (lncRNA) PITPNA antisense RNA 1 (PITPNA-AS1) expression characteristics, function, and mechanism in papillary thyroid cancer are unclear.
Shijuan Mei, Huafeng Zong, Haicheng Zhou
doaj +1 more source
Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and Recurrence [PDF]
Clinical and Experimental Otorhinolaryngology, 2022 Objectives Thyroid cancer is the most common endocrine tumor, with rapidly increasing incidence worldwide. However, its transcriptomic characteristics associated with immunological signatures, driver fusions, and recurrence markers remain unclear.
Seung-Jin Park +18 more
doaj +1 more source
The International Journal of Biological Markers, 2020 Thyroid cancer is the most common endocrine cancer in the world. Noting that the NOS3 gene polymorphism interferes with nitric oxide production, this study aims to identify and analyze the NOS3 gene polymorphism in the intron 4 region in patients with ...
Adara Rodrigues Damasceno Cerqueira +8 more
doaj +1 more source